Dr Emer MacSweeney Talks Cognition With Primal Cure TV

Re:Cognition Health’s CEO discusses setting up the company, developments in the health sector and why medical professionals need to work together to diagnose and treat neurological conditions

Re:Cognition Health: The Brain & Mind Experts

Dr MacSweeney co-founded Re:Cognition Health in 2011 to provide a comprehensive pathway to individuals experiencing issues with their cognition. The company’s vision is to become the recognised leader in the diagnosis, treatment and care management of individuals experiencing cognitive impairment. Re:Cognition Health has clinics in London, Guildford, Plymouth, Birmingham and Fairfax (USA). The company has 65 staff in the UK and 9 in the USA.

Diagnosing cognitive impairment

Dr MacSweeney explains why the complex diagnostic process of a neurological condition requires input from a multi-disciplinary team of experts.

New treatments for memory loss

Dr MacSweeney discusses the new Alzheimer’s treatments in the interview. These disease-modifying treatments could be more effective than current medications. Watch the interview to discover why clinical trials are important in changing the future for people with Alzheimer’s and dementia. Re:Cognition Health is currently running studies investigating new drugs for Lewy Body dementia, fronto-temporal dementia, vascular disease, Alzheimer’s disease as well as Parkinson’s disease.

Clinical trials for Alzheimer’s disease

Acknowledging that it’s been 15 years since a new medication for Alzheimer’s disease was licensed for global use, Dr MacSweeney highlights that only through research and education will we be able to find new treatments to stop the symptoms of memory problems from progressing. Clinical trials play an important role in the ongoing search for a cure for Alzheimer’s disease.


Back To All News